Ion implantation (doping) (process step)

Cross-cuts: Manufacturing
last updated 2026-06-20
Ion Implantation Ion Implantation Ion impla…

Step 25 of 56 in the semiconductor flow (FEOL). Prev: Wet etch / chemical surface prep (process step) · Next: Annealing / rapid thermal processing (process step)

What this step does

Ion implantation is how the electrical character of silicon gets written. Dopant atoms (boron, phosphorus, arsenic, and others) are ionised, accelerated to a chosen energy, and fired into the wafer to create the n-type and p-type regions that make a transistor work. The energy sets how deep the dopant goes; the beam current and dose set how many atoms arrive. The implanted lattice is left damaged and the dopant sits in the wrong (interstitial) sites, which is why the very next step, Annealing / rapid thermal processing (process step), heals the crystal and activates the dopant. Sub-processes inside this step:

Where it sits and why it matters

This is a defining FEOL step: a modern logic flow runs dozens of separate implant steps (well, channel, source/drain extension, halo, threshold-voltage adjust), each a distinct masked recipe. It is one of the few “additive” doping routes that places a precise number of atoms at a precise depth, which is why it has no real alternative for source/drain and well formation. It also sits at the centre of the power-device build (SiC and IGBTs lean on implant far more heavily than logic), which is the fastest-growing demand pocket.

Equipment market

The implanter equipment market is roughly $3.5B in 2024 counting systems plus aftermarket services; the systems-only pool is closer to $2.5-3B. Report-mill estimates scatter widely ($1.5B to $4B+) because of scope (machine-only vs. with services) and timing of the 2024 memory/logic downturn, so treat any single TAM as soft. SkyQuest puts the implanter market at ~$3.51B in 2024 growing to ~$4.99B by 2032 at ~4.5% CAGR; other sources claim 7-10%. The honest read: a low-to-mid-single-digit base CAGR for the mature logic/memory base, with SiC power as the high-growth overlay.

Vendor HQ Est. share (2024) Notable
Applied Materials US ~60-63% Dominant across all current segments; sold ~686 systems in 2024 (per QYResearch)
Axcelis Technologies US ~21% Purion platform; pure-play implant (98% of revenue); SiC power leader
Sumitomo Heavy / Nissin Ion Japan ~12-15% Strong Asia presence; ~90% of Japan SiC implanters, ~40% overseas
Advanced Ion Beam Tech (AIBT) Taiwan low single digit Niche / regional; China-facing
Hitachi High-Tech Japan low single digit Smaller line, specialty

Materials & consumables

Implant consumes specialty dopant gases (boron trifluoride BF3, phosphine PH3, arsine AsH3, plus diborane and germanium/carbon sources for advanced steps) and beam-line consumables (graphite/tungsten source parts, repellers, vacuum and abatement hardware). Dopant gases are a small, strategically vital slice of the ~$3B+ electronic specialty gas market; electronic-grade BF3 alone is roughly $200M in 2024 (mid-single-digit CAGR). Vendors:

Vendor HQ Notable
Merck KGaA / EMD Electronics Germany ION-X sub-atmospheric MOF dopant delivery (BF3, PH3, AsH3)
Air Liquide France Diborane, phosphine, arsine; broad electronics gases
Air Products US Industrial + electronic specialty gases
Linde UK/Germany Electronic gases incl. dopants
SIAD Italy Dopant gas supplier

Recurring-revenue note: gases and source parts are a steady aftermarket consumable, and the OEM aftermarket (service, spares, upgrades) is itself sticky. Axcelis CS&I aftermarket was $235.3M, 23.1% of 2024 revenue. The implant aftermarket overlaps with the Deposition Materials Process Market specialty-materials pool but is a smaller, more concentrated gas niche.

Volumes, revenue, profitability

Axcelis is the clean public proxy: $1,017.9M revenue in 2024, ~98% from implant, at 44.7% gross margin and 20.7% operating margin (down from 23.5% in 2023 on the downcycle). AMAT does not break out implant, but at ~3x Axcelis’s share its implant line is plausibly ~$1.5-2B. So the system+service revenue pool sits around $3.5B. Power devices were 56% of Axcelis 2024 system-shipment value, and Asia was 81% of system revenue. The margin is earned by the equipment OEMs (high-40s gross, ~20% operating at trough, higher at peak) and by the gas majors on the consumable; the value capture is overwhelmingly at the tool layer.

Competitive landscape & value capture

The moat is classic capital-equipment: beam physics know-how, a 20+ year qualified installed base, and service lock-in. Value accrues to two OEMs (AMAT, Axcelis) and a handful of specialty-gas majors. The interesting frontier is SiC / wide-bandgap power, which is implant-intensive (high-temperature, high-dose, high-energy recipes) and where Axcelis (Purion Power Series+) and Nissin lead. No credible EU or seed-stage tool challenger exists at the system level; barriers are too high. The European exposure is on the materials side (Merck/EMD, Air Liquide, Linde) and on the SiC device pull-through (EU automotive/power).

Net read: a cyclical trough now, with two structural pulls (advanced-logic implant-step growth, wide-bandgap power) setting up a faster recovery from ~2027 than the flat ~4.5% base CAGR implies.

Connections

Cluster: Ion Implantation Adjacent steps: Wet etch / chemical surface prep (process step) · Annealing / rapid thermal processing (process step) · Plasma / dry etch (process step) Theses: Deposition Materials Process Market

Sources

Recent mentions

Related concepts